Ionis Pharmaceuticals

Ionis Pharmaceuticals (Carlsbad, CA). 2024 revenue ~$1.0B. Antisense oligonucleotide (ASO) pioneer. Spinraza (nusinersen, mit Biogen). Tegsedi (inotersen). Wainua (eplontersen, 2025). GalNAc ASO platform.